Search Results - Anna P Durbin

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Cover Image

    Primary vaccination with low dose live dengue 1 virus generates a proinflammatory, multifunctional T cell response in humans. by Janet C Lindow, Nathan Borochoff-Porte, Anna P Durbin, Stephen S Whitehead, Kelly A Fimlaid, Janice Y Bunn, Beth D Kirkpatrick

    Published 2012
    Connect to this object online.
    Book

    Save to List
    Saved in:
  2. 2
    Cover Image

    A single dose of the DENV-1 candidate vaccine rDEN1Δ30 is strongly immunogenic and induces resistance to a second dose in a randomized trial. by Anna P Durbin, Stephen S Whitehead, Donna Shaffer, Dan Elwood, Kimberli Wanionek, Bhavin Thumar, Joseph E Blaney, Brian R Murphy, Alexander C Schmidt

    Published 2011
    Connect to this object online.
    Book

    Save to List
    Saved in:
  3. 3
    Cover Image

    Viridot: An automated virus plaque (immunofocus) counter for the measurement of serological neutralizing responses with application to dengue virus. by Leah C Katzelnick, Ana Coello Escoto, Benjamin D McElvany, Christian Chávez, Henrik Salje, Wensheng Luo, Isabel Rodriguez-Barraquer, Richard Jarman, Anna P Durbin, Sean A Diehl, Derek J Smith, Stephen S Whitehead, Derek A T Cummings

    Published 2018
    Connect to this object online.
    Book

    Save to List
    Saved in:
  4. 4
    Cover Image

    In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination. by Stephen S Whitehead, Anna P Durbin, Kristen K Pierce, Dan Elwood, Benjamin D McElvany, Ellen A Fraser, Marya P Carmolli, Cecilia M Tibery, Noreen A Hynes, Matthew Jo, Janece M Lovchik, Catherine J Larsson, Elena A Doty, Dorothy M Dickson, Catherine J Luke, Kanta Subbarao, Sean A Diehl, Beth D Kirkpatrick

    Published 2017
    Connect to this object online.
    Book

    Save to List
    Saved in:

Search Tools: